IDEXX Laboratories, Inc. (IDXX) Interest Coverage Ratio: 35.54x
The interest coverage ratio for IDEXX Laboratories, Inc. (IDXX) is 35.54x as of Wednesday, June 10, 2026.
IDXX Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
35.54x
IDXX Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $44.47B | 35.54x | N/A | N/A | N/A |
| Humana Inc. (HUM) | $43.78B | 2.30x | 2.38x | 5.10x | 7.90x |
| Agilent Technologies, Inc. (A) | $37.17B | 13.21x | 14.36x | 15.54x | 14.94x |
| Zoetis Inc. (ZTS) | $34.20B | 14.80x | 14.41x | 13.27x | 12.34x |
| Centene Corporation (CNC) | $31.94B | -11.24x | 4.28x | 3.30x | 3.63x |
| Medline Inc. (MDLN) | $30.90B | N/A | 1.38x | 1.23x | 1.23x |
| IQVIA Holdings Inc. (IQV) | $30.60B | 3.14x | 3.21x | 3.42x | 3.19x |
| DexCom, Inc. (DXCM) | $29.24B | 49.83x | 40.70x | 32.97x | 24.93x |
| Biogen Inc. (BIIB) | $29.00B | 7.63x | 8.79x | 9.45x | 11.57x |
| Veeva Systems Inc. (VEEV) | $26.73B | N/A | N/A | N/A | N/A |
Financial Health Indicators
Interest Coverage
35.5x
Debt/Equity
0.67
Current Ratio
1.17
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
IDEXX Laboratories, Inc. Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IDEXX Laboratories, Inc. Interest Coverage Ratio FAQ
- What is the interest coverage ratio for IDEXX Laboratories, Inc. (IDXX)?
- The interest coverage ratio for IDXX stock is 35.54x.
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jonathan J. Mazelsky